August 19, 2013

Bruker Announces the Appointment of Thomas Bachmann as Bruker BioSpin Group President

pr19082013 Thomas Bachmann

Thomas Bachmann

Bruker Corporation (NASDAQ: BRKR) today announced the appointment of Mr. Thomas Bachmann as its new Bruker BioSpin Group President.

BILLERICA, Mass. — August 19, 2013 – Bruker Corporation (NASDAQ: BRKR) today announced the appointment of Mr. Thomas Bachmann as its new Bruker BioSpin Group President. Mr. Bachmann most recently served as Chief Executive Officer of Tecan Group in Switzerland, a leading global provider of complex laboratory instrumentation and integrated liquid-handling workflow solutions for life science research and diagnostics.

The Bruker BioSpin Group is the global market and technology leader in analytical and preclinical magnetic resonance instrumentation, with expected calendar year 2013 revenue above $600 million, major operations in Germany, Switzerland, France and the United States, as well as numerous applications and customer service centers around the world. Today, the Bruker BioSpin Group operates in two divisions:

Magnetic Resonance Spectroscopy (MRS) division, consisting of the three business units nuclear magnetic resonance (NMR), electron paramagnetic resonance (EPR) and compact magnetic resonance (CMR).

Preclinical Imaging (PCI) division, consisting of the preclinical imaging product lines magnetic resonance imaging (MRI), magnetic particle imaging (MPI), X- ray micro-CT, as well as optical and PET/SPECT/CT molecular imaging.

Frank Laukien, Bruker’s President and Chief Executive Officer, stated: “I am very pleased to welcome Thomas Bachmann to Bruker. His complementary life-science customer background and his broad management experience will allow him to lead our already excellent Bruker BioSpin management team in order to further accelerate our innovation, profitable growth and operational excellence initiatives.  Thomas will also be a valuable addition for all of Bruker due to his diversified industrial experience, his global customer and operations exposure, and his successful track record.”

“Bruker is a premier brand in our analytical, life-science and diagnostic instruments industry, and an exceptional company that I have come to know well over the past few years,” said Thomas Bachmann. “I am delighted to join Bruker, and together with an experienced management team I look forward to successfully developing the Bruker BioSpin Group further. With emphasis on continuous innovation for our customers, novel applications development and further market expansion, paired with operational excellence and margin expansion, Bruker BioSpin has significant value creation potential over the years to come.”

Thomas Bachmann brings over twenty-five years of global experience in sales and marketing, in leading and transforming complex businesses, as well as in strategy and business development to his new role as Bruker BioSpin Group President, including experience as CEO in two publicly traded companies. From 2005 until 2012, Mr. Bachmann served as CEO of Tecan Group, where he increased operational effectiveness, expanded into new businesses, developed emerging markets, created a solid organization, established regulatory competence and compliance, grew profitability and built a strong balance sheet. From 2002 until 2004, he was CEO of the Arbonia-Forster Group’s Steel Systems Business, a global provider of building supplies. From 1985 until 2002, Mr. Bachmann served in various roles as global Sales and Marketing Director, Business Unit Director and Senior Vice President of Corporate Development at Rieter Holding, a global provider of textile machinery and plants, as well as an automotive supplier of acoustic- and thermal insulation systems. Mr. Bachmann holds a B.Sc. in Mechanical Engineering and an Executive MBA from IMD Business School in Switzerland.

About Bruker Corporation
Bruker Corporation (NASDAQ: BRKR) is a leading provider of high performance scientific instruments and solutions for molecular and materials research, as well as industrial, diagnostics and applied analysis.

For more information, please visit www.bruker.com

Media Contact:
Dr. Thorsten Thiel
Bruker Director of Marketing Communications

T: +49 (721) 5161 – 6500
E: thorsten.thiel(at)bruker.com